{"id":"combined-with-voriconazole","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action is not well understood, but it is thought to involve the inhibition of a key enzyme in the metabolic pathway of a specific disease-causing organism. This inhibition leads to a reduction in the growth and proliferation of the organism, ultimately resulting in the alleviation of symptoms.","oneSentence":"This drug works by inhibiting the activity of a specific enzyme.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:27:40.880Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of invasive aspergillosis when used in combination with voriconazole"}]},"trialDetails":[{"nctId":"NCT06928376","phase":"PHASE2","title":"A Multicenter RCT of \"3+7\" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2024-04-18","conditions":"Acute Myeloid Leukemia, First Line Therapy","enrollment":160},{"nctId":"NCT07396480","phase":"PHASE3","title":"Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial","status":"RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2026-03-01","conditions":"Venentoclax, Myeloid Malignancies, Conditioning","enrollment":186},{"nctId":"NCT07362693","phase":"","title":"A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA","status":"NOT_YET_RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2025-12-31","conditions":"ABPA, Biologics, Allergic Bronchopulmonary Aspergillosis (ABPA)","enrollment":50},{"nctId":"NCT06068621","phase":"PHASE2","title":"Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Chinese PLA General Hospital","startDate":"2023-03-01","conditions":"Acute Myeloid Leukemia","enrollment":200},{"nctId":"NCT07320235","phase":"PHASE1","title":"Imetelstat Combinations in Relapsed AML","status":"RECRUITING","sponsor":"Douglas Tremblay","startDate":"2026-01","conditions":"Relapsed Acute Myeloid Leukemia","enrollment":36},{"nctId":"NCT03013998","phase":"PHASE1, PHASE2","title":"Study of Biomarker-Based Treatment of Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Beat AML, LLC","startDate":"2016-11","conditions":"Previously Untreated Relapsed Refractory Acute Myeloid Leukemia","enrollment":3000},{"nctId":"NCT06129734","phase":"PHASE1, PHASE2","title":"Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant","status":"RECRUITING","sponsor":"Benjamin Tomlinson","startDate":"2025-07-28","conditions":"Myeloid Malignancy, Acute Myeloid Leukemia","enrollment":20},{"nctId":"NCT07101497","phase":"PHASE2","title":"Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2025-08-01","conditions":"Menin Inhibitors, Post Hematopoietic Stem Cell Transplantation, Maintenance Therapy","enrollment":60},{"nctId":"NCT04865419","phase":"PHASE1","title":"Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2021-06-11","conditions":"Haematological Malignancies","enrollment":46},{"nctId":"NCT06926569","phase":"NA","title":"Single High-dose of Liposomal Amphotericin B in Combination With B/F/TAF for HIV/AIDS-associated Talaromycosis","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Public Health Clinical Center","startDate":"2025-05-01","conditions":"HIV/AIDS-associated Talaromycosis","enrollment":116},{"nctId":"NCT04876716","phase":"PHASE3","title":"Azole-echinocandin Combination Therapy for Invasive Aspergillosis","status":"TERMINATED","sponsor":"Erasmus Medical Center","startDate":"2021-05-11","conditions":"Invasive Aspergillosis","enrollment":66},{"nctId":"NCT05918198","phase":"PHASE2","title":"Clinical Study of Venetoclax Combined With CAG in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia","status":"UNKNOWN","sponsor":"Peking University People's Hospital","startDate":"2023-02-01","conditions":"Acute Myeloid Leukemia","enrollment":52},{"nctId":"NCT06044558","phase":"","title":"Effect of Azole/Echinocandin Use on Tacrolimus Pharmacokinetics","status":"COMPLETED","sponsor":"LI YAN","startDate":"2022-09-01","conditions":"Kidney Transplant Patients","enrollment":507},{"nctId":"NCT05456048","phase":"","title":"Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML","status":"COMPLETED","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2018-12-03","conditions":"Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Gene Abnormality","enrollment":231},{"nctId":"NCT02366884","phase":"PHASE2","title":"Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011)","status":"UNKNOWN","sponsor":"Dr. Frank Arguello Cancer Clinic","startDate":"2011-07-26","conditions":"Neoplasms","enrollment":250},{"nctId":"NCT05268718","phase":"EARLY_PHASE1","title":"Au-Ag-Cu2O NG With PTT Anti Drug-resistant Microbial Keratitis","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2021-08-01","conditions":"Keratitis, Ulcerative, Antibiotic Resistance, Microbial, Photothermal Therapy","enrollment":20},{"nctId":"NCT04072640","phase":"EARLY_PHASE1","title":"Three Induction Treatments on Cryptococcal Meningitis","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2021-01-25","conditions":"Cryptococcal Meningitis, HIV/AIDS","enrollment":120},{"nctId":"NCT03230058","phase":"PHASE2, PHASE3","title":"Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis","status":"UNKNOWN","sponsor":"L.V. Prasad Eye Institute","startDate":"2017-01-01","conditions":"Infection, Fungal","enrollment":55},{"nctId":"NCT02381080","phase":"PHASE1","title":"Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-05-19","conditions":"B-Cell Chronic Lymphocytic Leukemia","enrollment":26},{"nctId":"NCT01787032","phase":"PHASE1","title":"Drug-drug Interaction Trial of BI 113608 in Combination With Ketoconazole and Voriconazole in Healthy Male Subjects","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2013-01","conditions":"Healthy","enrollment":20},{"nctId":"NCT01501708","phase":"PHASE2","title":"Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2011-12","conditions":"Leukemia, Transplantation, Hematopoietic Stem Cell","enrollment":55},{"nctId":"NCT02068170","phase":"","title":"Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital","status":"COMPLETED","sponsor":"KU Leuven","startDate":"2014-02","conditions":"Delirium, QT-prolongation","enrollment":178},{"nctId":"NCT00003031","phase":"PHASE3","title":"Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis","status":"COMPLETED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1997-06","conditions":"Infection, Pulmonary Complications","enrollment":212},{"nctId":"NCT01188759","phase":"PHASE3","title":"Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects","status":"WITHDRAWN","sponsor":"Pfizer","startDate":"2012-05","conditions":"Aspergillosis, Invasive Pulmonary Aspergillosis, Neuroaspergillosis","enrollment":""},{"nctId":"NCT00531479","phase":"PHASE3","title":"Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-07","conditions":"Aspergillosis","enrollment":459},{"nctId":"NCT01207128","phase":"PHASE2","title":"Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis","status":"WITHDRAWN","sponsor":"University of Arkansas","startDate":"2011-02","conditions":"Aspergillosis","enrollment":""},{"nctId":"NCT00620074","phase":"PHASE4","title":"Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)","status":"TERMINATED","sponsor":"Pfizer","startDate":"2008-08","conditions":"Aspergillosis","enrollment":6}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1964,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["tacrolimus","methylprednisolone sodium succinate","mycophenolate sodium"],"phase":"phase_2","status":"active","brandName":"Combined with voriconazole","genericName":"Combined with voriconazole","companyName":"LI YAN","companyId":"li-yan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug works by inhibiting the activity of a specific enzyme. Used for Treatment of invasive aspergillosis when used in combination with voriconazole.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}